honoluluadvertiser.com

Sponsored by:

Comment, blog & share photos

Log in | Become a member
The Honolulu Advertiser

Posted at 11:56 a.m., Friday, August 19, 2005

Stocks mixed after verdict against Merck

Associated Press

spacer
NEW YORK — Stocks ended an uneasy week mostly higher today as a jury verdict against Merck & Co. over its painkiller Vioxx erased much of an earlier advance fueled by bargain hunting. The major indexes all suffered losses for the week.

Wall Street quickly pulled back late today after a Texas court found Merck liable for the death of a man who took Vioxx, and awarded his estate more than $250 million in damages. Merck shares dropped $2.35, or 7.7 percent, to $28.06 at the close of trading.

The overall market still managed a small gain as bargain hunters took advantage of recent declines and bought up underperforming stocks. Positive analyst reports on Coca-Cola Inc. and International Business Machines Corp., as well as indications of continued growth in China from Caterpillar Inc., also encouraged investors.

The advance also held despite a jump in crude oil futures, which rose on news of demonstrations in Ecuador that have disrupted oil exports. A barrel of light crude surged $2.08 to settle at $65.35 on the New York Mercantile Exchange.

The Dow Jones industrial average rose 4.30, or 0.04 percent, to close at 10,559.23.

Broader stock indicators finished mixed. The Standard & Poor's 500 index gained 0.69, or 0.1 percent, to 1,219.71, while the Nasdaq composite index slipped 0.52, or 0.02 percent, to 2,135.56.

Bonds were even despite stocks rising, with the yield on the 10-year Treasury note unchanged at 4.21 percent. The dollar was mixed against other major currencies, while gold prices inched lower.

Trading was expected to be volatile during today's session on Wall Street due to the expiration of monthly futures contracts, which customarily prompts investors to make shifts in their holdings.

While stocks gave up some of their gains after the Merck verdict, the market's reaction was nonetheless muted as investors had previously factored in major Vioxx liability into the drug maker's stock. Pfizer Inc., whose painkillers Bextra and Celebrex are similar to Vioxx, fell 33 cents to $25.55, while Eli Lilly & Co. closed down 5 cents at $52.57.

Despite today's gain, stocks were pressured for much of the week by evidence of inflation brought on by higher energy costs, especially after the government's inflation reports showed big jumps in wholesale and consumer prices during July. The Dow fell 0.39 percent for the week while the S&P 500 lost 0.87 percent and the Nasdaq dropped 0.99 percent.

Wall Street has languished this month after rallying in July on strong corporate earnings and growth in the economy. Uncertainty about where the market is headed has had investors trading lightly as they grapple with the effects of soaring oil prices amid improved economic data and persistently low interest rates.

But analysts found some positive signs.

"I guess all things considered, the market's been pretty impressive in the face of oil prices," said Barry Berman, head trader at Robert W. Baird & Co. "It would appear that way looking at the fact that interest rates are still low on a relative basis. Lower rates are going to keep the economy going."

Dow component Coca-Cola fueled the mildly bullish sentiment early in today's session. Analysts at UBS upgraded the stock to "buy" from "neutral," citing the company's stronger marketing efforts and improved sales forecasts. Coca-Cola gained 86 cents to $44.39.

IBM added $1.61 to $82.76 following a report from Prudential Securities that said the company is poised for a strong second half, when clients often increase spending. Prudential analysts also noted IBM is benefiting from layoffs and remains a better pick than rival Hewlett-Packard Co.

News of industrial growth in China lifted Caterpillar, another Dow component, which rose $1.67 to $54.82. The world's top maker of heavy machinery said it signed three nonbinding deals with a government-affiliated industrial developer in China.

Autodesk Inc. climbed $2.06 to $40.41 after reporting second-quarter profits that nearly doubled from a year ago. The maker of engineering software credited a 33 percent jump in sales for the strong results, and raised its profit forecasts for the full year.

Despite posting a strong second quarter, Gap Inc. fed concerns about the retail sector after lowering its profit estimates for the year due to weaker sales. Gap beat quarterly profit expectations by 2 cents per share, but the fashion chain nonetheless fell 41 cents to finish at $19.74.

However, AnnTaylor Stores Corp. jumped $1.56, or 6.2 percent, to close at $26.60 even after the clothing retailer's second-quarter profits fell from softer sales. The company nonetheless exceeded Wall Street's expectations by a penny per share, and said improved margins would help it meet previously stated full-year profit targets.

Advancing issues outnumbered decliners by about 9 to 7 on the New York Stock Exchange, where preliminary consolidated volume came to 1.56 billion shares, compared with 1.83 billion at the close of trading yesterday.

The Russell 2000 index of smaller companies rose 1.32, or 0.2 percent, to 652.51.

Overseas, Japan's Nikkei stock average fell 0.13 percent. In afternoon trading, Britain's FTSE 100 was up 0.82 percent, Germany's DAX index surged 1.62 percent, and France's CAC-40 rose 1.31 percent.

———

The Dow Jones industrials ended the week down 41.08, or 0.39 percent, finishing at 10,559.23. The S&P 500 index fell 10.68, or 0.87 percent, to close at 1,219.71.

The Nasdaq dropped 21.34, or 0.99 percent, during the week, closing today at 2,135.56.

The Russell 2000 index closed the week down 7.49, or 1.13 percent, at 652.51.

The Dow Jones Wilshire 5000 Composite Index — a free-float weighted index that measures 5,000 U.S. based companies — ended the week at 12,167.91, down 115.88 points from last week.